vTv Therapeutics (NASDAQ:VTVT) Coverage Initiated by Analysts at StockNews.com

Equities research analysts at StockNews.com began coverage on shares of vTv Therapeutics (NASDAQ:VTVT – Get Free Report) in a research report issued on Saturday. The brokerage set a “sell” rating on the biotechnology company’s stock. Separately, Alliance Global Partners assumed coverage on shares of vTv Therapeutics in a research report on Monday, December 9th. They […]